WEDNESDAY, MARCH 30, 2011
09:00-12:00 EASL-IAC (International Club of Ascites) Joint Workshop: RENAL DYSFUNCTION IN
CIRRHOSIS IN THE ERA OF AKI: TOWARDS A NEW DEFINITION Chairs: M. Bernardi, Italy P.
Angeli. Italy
09:00 Introduction: Renal dysfunction in patients with cirrhosis: the long way traveled so
far by hepatologists V. Arroyo, Spain Critical points in the actual definitions of renal
dysfunction in cirrhosis
09:15 The definition of renal dysfunction in cirrhosis in the era of AKI ; is a 0.3 mg/dl
change enough in the setting of cirrhosis for diagnosis of AKI? M. Nadim, USA
09:30 The actual “grey zones” about the classification of patients with cirrhosis and
renal dysfunction. F. Wong, Canada
09:45 How to improve the differential diagnosis among HRS and ATN? C. Parihk, USA
10:00 Discussion S. Møller, Denmark C.L. Davis, USA Critical points in the treatment of
renal dysfunction in cirrhosis
10:15 How to optimize the pharmacological treatment for type 1 HRS A.J. Sanyal, USA
10:30 Coffee Break
11:00 What after the failure of vasoconstrictors and albumin in order to be effective and
to avoid futility? Extracorporeal renal and/or hepatic support, TIPS F. Salerno, Italy
11:15 Combined liver and kidney transplantation (CLKT): when is it indicated in patients
with cirrhosis and renal dysfunction? C.L. Davis, USA
11:30 Discussion M. Guevara, Spain M. Nadim, USA
11:45 Conclusions: Proposal of a new classification of renal dysfunction in patients with
cirrhosis: towards a consensus based on a multidisciplinary approach ? P. Ginès, Spain